By reducing inflammation, semaglutide helps improve overall cardiovascular health, including better cholesterol levels
It is important to note that this mechanism, while biologically plausible, is not yet validated by large-scale controlled trials, and individual results vary considerably depending on baseline melanin levels, skin type, and dosage
When compared against the average risk score for a diabetic member, diabetic members not taking GLP-1s are riskier than average, while those taking GLP-1s were less risky than averageand, by a wider margin
doi: 10.1111/j.1365-2265.1994.tb02486.x 12 BieringHKnappeGGerlHLochsH
Check your plan coverage details to know if you are eligible